Clinical Trial Update: S9912 Combination Chemo in Stage III Ovarian Cancer, [Phase 2]

View source ↗

Summary

Phase 2 trial S9912 evaluated a combination chemotherapy regimen in stage III ovarian cancer; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-11-29